Metraipolis › archive › dc_4d6dcd7955ff
Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective — Europe PMC PMID:41648065
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41648065
- DOI
- 10.31138/mjr.101025.erh
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:49:32.876Z
- SHA-256 of the archived text
2dedd11ebec51e4a4008369ecab2faeaa750f6341fcc7a915911b9cdc3a72005- Stable URL of this page
https://metraipolis.com/documento/dc_4d6dcd7955ff
How to cite
Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective — Europe PMC PMID:41648065 — Europe PMC (en), https://europepmc.org/article/MED/41648065 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d6dcd7955ff (Metraipolis archive dc_4d6dcd7955ff, sha256 2dedd11ebec51e4a4008369ecab2faeaa750f6341fcc7a915911b9cdc3a72005)
BibTeX
@misc{dc4d6dcd7955ff,
title = {Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective — Europe PMC PMID:41648065},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41648065},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d6dcd7955ff; sha256 2dedd11ebec51e4a4008369ecab2faeaa750f6341fcc7a915911b9cdc3a72005},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41648065. Agents can read the archived copy with the MCP tool read_document.